Rosiglitazone inhibits RANTES expression by human epidermal keratinocytes.
Zhang
Min
M
Chen
Jing
J
Guo
Zaipei
Z
Li
Li
L
Zhang
Yizhi
Y
Li
Jianwei
J
D002460:Cell Line; D018946:Chemokine CCL5 / Q000096:biosynthesis*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology; D015603:Keratinocytes / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D000077154:Rosiglitazone; D015398:Signal Transduction; D045162:Thiazolidinediones / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D018946:Chemokine CCL5; D045162:Thiazolidinediones; D014409:Tumor Necrosis Factor-alpha; D000077154:Rosiglitazone; D007371:Interferon-gamma